Meloxicam
Back to searchMolecule Structure
Scientific Name
Meloxicam
Description of the Drug
Meloxicam is an NSAID used to treat osteoarthritis in adults, rheumatoid arthritis in adults, and juvenile rheumatoid arthritis in pediatrics.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00814
http://www.drugbank.ca/drugs/DB00814
Brand Name(s)
Anjeso, Meloxicam, Mobic, Qmiiz odt, Vivlodex
Company Owner(s)
Cipla Ltd, Iceutica Operations Llc, Sun Pharmaceutical Industries Inc, Tersera Therapeutics Llc, Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Novitium Pharma Llc, Boehringer Ingelheim Pharmaceuticals Inc, Anda Repository Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cyclooxygenase-2 | SINGLE PROTEIN | INHIBITOR | CHEMBL230 |
Clinical Trial(s)
Unichem Links
Atlas | meloxicam | ||||||
SureChEMBL | SCHEMBL3576 | SCHEMBL23589638 | |||||
Human Metabolome Database | HMDB0014952 | ||||||
DrugBank | DB00814 | ||||||
PubChem: Thomson Pharma | 14754262 | ||||||
PubChem | 54677470 | ||||||
Mcule | MCULE-4138373089 | ||||||
NMRShiftDB | 60027946 | ||||||
Nikkaji | J22.773K | ||||||
PDBe | MXM | ||||||
BindingDB | 50056998 | ||||||
EPA CompTox Dashboard | DTXSID1020803 | ||||||
DrugCentral | 1676 | ||||||
Metabolights | MTBLC6741 | ||||||
Brenda | 5320 | 74731 | |||||
ChemicalBook | CB2191355 | ||||||
Guide to Pharmacology | 7220 | ||||||
rxnorm | MELOXIDYL | MOBIC | VIVLODEX | LOXICOM | METACAM | ANJESO | MELOXICAM |
PubChem: Drugs of the Future | 12013466 | ||||||
KEGG Ligand | C08169 | ||||||
ChEBI | 6741 | ||||||
ZINC | ZINC000013129998 |